Literature DB >> 31119671

El-MAVEN: A Fast, Robust, and User-Friendly Mass Spectrometry Data Processing Engine for Metabolomics.

Shubhra Agrawal1, Sahil Kumar1, Raghav Sehgal1, Sabu George1, Rishabh Gupta1, Surbhi Poddar1, Abhishek Jha2, Swetabh Pathak3.   

Abstract

Analysis of large metabolomic datasets is becoming commonplace with the increased realization of the role that metabolites play in biology and pathophysiology. While there are many open-source analysis tools to extract peaks from liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), and tandem mass spectrometry (LC-MS/MS) data, these tools are not very interactive and are suboptimal when a large number of samples are to be analyzed. El-MAVEN is an open-source analysis platform that extends MAVEN and provides fast, powerful, and interactive analysis capabilities especially for datasets containing over 100 samples. The El-MAVEN workflow is easy to use with just four steps from loading data to exporting of the results. Advanced analysis and software techniques such as multiprocessing, machine learning, and reduction of memory leaks are implemented so as to provide a seamless and interactive user experience. Results from El-MAVEN can be exported in a range of formats allowing continued analysis on other platforms. Additionally, El-MAVEN is also fully integrated with Polly™, a cloud-based analysis platform that provides a range of tools for flux analysis and integrative-omics analysis. El-MAVEN is a powerful tool that enables fast and efficient analysis of large metabolomic datasets to accelerate the process of gaining insight from raw data.

Entities:  

Keywords:  Bioinformatics; Data analysis; Data processing; Liquid chromatography-mass spectrometry; MAVEN; Mass spectrometry; Metabolic pathways; Metabolomics

Mesh:

Year:  2019        PMID: 31119671     DOI: 10.1007/978-1-4939-9236-2_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

Review 1.  Interrogating in vivo T-cell metabolism in mice using stable isotope labeling metabolomics and rapid cell sorting.

Authors:  Ryan D Sheldon; Eric H Ma; Lisa M DeCamp; Kelsey S Williams; Russell G Jones
Journal:  Nat Protoc       Date:  2021-08-04       Impact factor: 13.491

2.  Improved Annotation of Untargeted Metabolomics Data through Buffer Modifications That Shift Adduct Mass and Intensity.

Authors:  Wenyun Lu; Xi Xing; Lin Wang; Li Chen; Sisi Zhang; Melanie R McReynolds; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2020-08-12       Impact factor: 6.986

3.  Selenium Modulates Cancer Cell Response to Pharmacologic Ascorbate.

Authors:  Connor S R Jankowski; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2022-10-04       Impact factor: 13.312

4.  Global stable-isotope tracing metabolomics reveals system-wide metabolic alternations in aging Drosophila.

Authors:  Ruohong Wang; Yandong Yin; Jingshu Li; Hongmiao Wang; Wanting Lv; Yang Gao; Tangci Wang; Yedan Zhong; Zhiwei Zhou; Yuping Cai; Xiaoyang Su; Nan Liu; Zheng-Jiang Zhu
Journal:  Nat Commun       Date:  2022-06-20       Impact factor: 17.694

5.  Power of mzRAPP-Based Performance Assessments in MS1-Based Nontargeted Feature Detection.

Authors:  Yasin El Abiead; Maximilian Milford; Harald Schoeny; Mate Rusz; Reza M Salek; Gunda Koellensperger
Journal:  Anal Chem       Date:  2022-06-07       Impact factor: 8.008

6.  Applications of Chromatography-Ultra High-Resolution MS for Stable Isotope-Resolved Metabolomics (SIRM) Reconstruction of Metabolic Networks.

Authors:  Qiushi Sun; Teresa W-M Fan; Andrew N Lane; Richard M Higashi
Journal:  Trends Analyt Chem       Date:  2019-10-01       Impact factor: 12.296

7.  TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.

Authors:  Rachael E Maynard; Brad Poore; Allison R Hanaford; Khoa Pham; Madison James; Jesse Alt; Youngran Park; Barbara S Slusher; Pablo Tamayo; Jill Mesirov; Tenley C Archer; Scott L Pomeroy; Charles G Eberhart; Eric H Raabe
Journal:  Cancer Lett       Date:  2021-02-08       Impact factor: 9.756

8.  Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.

Authors:  Manu Vanaerschot; James M Murithi; Charisse Flerida A Pasaje; Sonja Ghidelli-Disse; Louis Dwomoh; Megan Bird; Natasha Spottiswoode; Nimisha Mittal; Lauren B Arendse; Edward S Owen; Kathryn J Wicht; Giulia Siciliano; Markus Bösche; Tomas Yeo; T R Santha Kumar; Sachel Mok; Emma F Carpenter; Marla J Giddins; Olalla Sanz; Sabine Ottilie; Pietro Alano; Kelly Chibale; Manuel Llinás; Anne-Catrin Uhlemann; Michael Delves; Andrew B Tobin; Christian Doerig; Elizabeth A Winzeler; Marcus C S Lee; Jacquin C Niles; David A Fidock
Journal:  Cell Chem Biol       Date:  2020-04-30       Impact factor: 8.116

9.  Palbociclib treatment alters nucleotide biosynthesis and glutamine dependency in A549 cells.

Authors:  Lindsey R Conroy; Pawel Lorkiewicz; Liqing He; Xinmin Yin; Xiang Zhang; Shesh N Rai; Brian F Clem
Journal:  Cancer Cell Int       Date:  2020-07-01       Impact factor: 5.722

10.  Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.

Authors:  James M Murithi; Edward S Owen; Eva S Istvan; Marcus C S Lee; Sabine Ottilie; Kelly Chibale; Daniel E Goldberg; Elizabeth A Winzeler; Manuel Llinás; David A Fidock; Manu Vanaerschot
Journal:  Cell Chem Biol       Date:  2019-12-05       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.